Clinical trial
Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast…
NCT00244959 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00244959 |
|---|---|
| Title | Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer |
| Official title | Surrogate Markers of Response: A Phase II Study of Changes in Breast Density Among Postmenopausal Women Receiving Adjuvant Anastrozole Therapy |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | anastrozole, adjuvant therapy |
| Enrollment | 54 |
| Start date | Jan 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Nov 1, 2011 |
| First posted | Oct 27, 2005 |
| Last update posted | Mar 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: